首页 > 市场调查报告书 > 製药

疫苗感染疾病

市场调查报告书

商品编码

1671882

疟疾疫苗市场：按疫苗类型、按药剂、按年龄组、按分销管道、按最终用户、按地区

Malaria Vaccines Market, By Vaccine Type, By Agent, By Age, By Distribution Channel, By End Users, By Geography

出版日期: 2025年02月06日 | 出版商:

Coherent Market Insights | 英文 166 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球疟疾疫苗市场规模估计为 6.2 亿美元，预计到 2032 年将达到 14.327 亿美元，2025 年至 2032 年的复合年增长率为 12.7%。

报告范围		报告详细信息
基准年	2024	2025 年市场规模	6.2亿美元
效能资料	2020-2024	预测期	2025-2032
预测期：2025-2032年复合年增长率：	12.70％	2032 年价值预测	14.327亿美元

图。

疟疾是一种危及生命的疾病，由一种透过受感染的疟蚊叮咬传播给人类的寄生虫所引起。目前可用的疟疾预防和控制策略，如杀虫剂处理的蚊帐、杀虫剂喷洒和抗疟疾药，已被证明不足以遏制疾病的传播。因此，疟疾疫苗已成为减少疟疾流行地区发病率和死亡率的迫切且重要的公共卫生工具。疫苗可以提供持久的免疫力，而不需要大规模的医疗保健基础设施，因此可以为消除疟疾的目标提供经济有效且永续的解决方案。

市场动态：

全球疟疾疫苗市场主要受全球尤其是非洲国家的疟疾高疾病负担、全球卫生组织对疟疾疫苗研发的大量资助以及疫苗作为重要公共卫生干预措施的日益接受所推动。然而，由于疟疾原虫的生命週期复杂以及对保护性免疫反应缺乏全面的了解，开发有效的疟疾疫苗的技术挑战继续限制市场潜力。同时，疫苗学、免疫学和病原体基因组学的进步为开发新型疫苗设计方法和抗原标靶创造了机会。此外，世界卫生组织（WHO）、卫生适宜技术规划署、疟疾疫苗倡议（PATH MVI）和政府免疫规划之间的协调努力可以扩大生产能力并成功地将疟疾疫苗送到当地人群手中。

本研究的主要特点

本报告对全球疟疾疫苗市场进行了详细分析，并提供了预测期（2025-2032）的市场规模和年复合成长率（CAGR%），假设 2025 年为基准年。

它还强调了各个领域的潜在商机，并说明了该市场的引人注目的投资提案矩阵。

它还提供了关于市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的主要考察。

全球疟疾疫苗市场的主要企业是根据公司亮点、产品系列、关键亮点、业绩和策略等参数列出的。

研究涉及的主要企业包括葛兰素史克公司、Sanaria Inc.、Nobelpharma Co.、Sumaya Biotech、GenVec、默克公司、辉瑞公司、强生公司、Bharat Biotech、印度血清研究所、武田製药公司、Novavax, Inc.、Inovio Pharmaceuticals、Vaxart, Inc. 和 BioNTech SE。

本报告提供的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。

全球疟疾疫苗市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。

相关人员将透过用于分析全球疟疾疫苗市场的各种策略矩阵来做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 620.0 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	12.70%	2032 Value Projection:	USD 1,432.7 Mn

Malaria is a life-threatening disease caused by parasites that are transmitted to people through the bites of infected Anopheles mosquitoes. The currently available strategies for malaria prevention and control such as insecticide treated nets, spraying of insecticides and antimalarial drugs are proving insufficient to curb the spread of the disease. This makes malaria vaccines an urgent and vital public health tool to reduce malaria morbidity and mortality in endemic regions. Vaccines can provide long lasting immunity without requiring large healthcare infrastructure, thereby offering a cost-effective and sustainable solution towards malaria elimination goals.

Market Dynamics:

The global malaria vaccines market is primarily driven by the high disease burden of malaria worldwide, especially in African countries, massive funding for malaria vaccine development from global health organizations and growing acceptance of vaccines as an important public health intervention. However, technical challenges in developing an effective malaria vaccine owing to the complex life cycle of parasite Plasmodium and lack of comprehensive understanding of protective immune responses continue to restrain market potential. Meanwhile, ongoing advancements in vaccinology, immunology, and pathogen genomics have created opportunities for the development of novel vaccine design approaches and antigen targets. Further opportunities lie in expanding manufacturing capacity and ensuring successful uptake of malaria vaccines, once available, in malaria endemic populations through coordinated efforts of World Health Organization (WHO), Program for Appropriate Technology in Health, Malaria Vaccine Initiative (PATH MVI), and government immunization programs.

Key Features of the Study:

This report provides in-depth analysis of the global malaria vaccines market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2025 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global malaria vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include GlaxoSmithKline plc, Sanaria Inc., Nobelpharma Co., Sumaya Biotech, GenVec, Merck & Co., Inc., Pfizer Inc., Johnson & Johnson, Bharat Biotech, Serum Institute of India, Takeda Pharmaceutical Company, Novavax, Inc., Inovio Pharmaceuticals, Vaxart, Inc., and BioNTech SE

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global malaria vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global malaria vaccines market

Market Segmentation

Vaccine Type Insights (Revenue, USD Mn, 2020 - 2032)
- Pre-Erythrocytic Vaccines
- Erythrocytic Vaccines
- Multi-Antigen Vaccines
Agent Insights (Revenue, USD Mn, 2020 - 2032)
- Plasmodium Falciparum
- Plasmodium Vivax
- Anopheles Species
Age Insights (Revenue, USD Mn, 2020 - 2032)
- Pediatric
- Adult
Distribution Channel Insights (Revenue, USD Mn, 2020 - 2032)
- Public
- Private
End Users Insights (Revenue, USD Mn, 2020 - 2032)
- Hospitals
- Specialty Clinics
- Community Health Centers
- Homecare
Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- GlaxoSmithKline plc
- Sanaria Inc.
- Nobelpharma Co.
- Sumaya Biotech
- GenVec
- Merck & Co., Inc.
- Pfizer Inc.
- Johnson & Johnson
- Bharat Biotech
- Serum Institute of India
- Takeda Pharmaceutical Company
- Novavax, Inc.
- Inovio Pharmaceuticals
- Vaxart, Inc.
- BioNTech SE

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Malaria Vaccines Market, By Vaccine Type
- Global Malaria Vaccines Market, By Agent
- Global Malaria Vaccines Market, By Age
- Global Malaria Vaccines Market, By Distribution Channel
- Global Malaria Vaccines Market, By End Users
- Global Malaria Vaccines Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Malaria Vaccines Market, By Vaccine Type, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pre-Erythrocytic Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Erythrocytic Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Multi-Antigen Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Malaria Vaccines Market, By Agent, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Plasmodium Falciparum
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Plasmodium Vivax
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Anopheles Species
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Malaria Vaccines Market, By Age, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Malaria Vaccines Market, By Distribution Channel, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Public
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Malaria Vaccines Market, By End Users, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Community Health Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Homecare
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Malaria Vaccines Market, By Region, 2020 - 2032, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Agent, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- U.S.
- Canada
Latin America
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Agent, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Agent, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Agent, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Agent, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Agent, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
- South Africa
- North Africa
- Central Africa

10. Competitive Landscape

GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanaria Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Nobelpharma Co.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sumaya Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GenVec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc.
Pfizer Inc.
Johnson & Johnson
Bharat Biotech
Serum Institute of India
Takeda Pharmaceutical Company
Novavax, Inc.
Inovio Pharmaceuticals
Vaxart, Inc.
BioNTech SE

11. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

疟疾疫苗市场：按疫苗类型、按药剂、按年龄组、按分销管道、按最终用户、按地区